BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28719045)

  • 1. MICAL2 promotes breast cancer cell migration by maintaining epidermal growth factor receptor (EGFR) stability and EGFR/P38 signalling activation.
    Wang Y; Deng W; Zhang Y; Sun S; Zhao S; Chen Y; Zhao X; Liu L; Du J
    Acta Physiol (Oxf); 2018 Feb; 222(2):. PubMed ID: 28719045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MICAL-L2 potentiates Cdc42-dependent EGFR stability and promotes gastric cancer cell migration.
    Min P; Zhao S; Liu L; Zhang Y; Ma Y; Zhao X; Wang Y; Song Y; Zhu C; Jiang H; Gu L; Du J
    J Cell Mol Med; 2019 Jun; 23(6):4475-4488. PubMed ID: 31034158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MICAL2 contributes to gastric cancer cell migration via Cdc42-dependent activation of E-cadherin/β-catenin signaling pathway.
    Wang Q; Qi C; Min P; Wang Y; Ye F; Xia T; Zhang Y; Du J
    Cell Commun Signal; 2022 Sep; 20(1):136. PubMed ID: 36064550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI-3 kinase/Akt.
    Brusevold IJ; Aasrum M; Bryne M; Christoffersen T
    J Oral Pathol Med; 2012 Aug; 41(7):547-58. PubMed ID: 22413835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.
    Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T
    J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells.
    Deng W; Gu L; Li X; Zheng J; Zhang Y; Duan B; Cui J; Dong J; Du J
    J Transl Med; 2016 Feb; 14():32. PubMed ID: 26830684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance.
    Lu J; Li Y; Wu Y; Zhou S; Duan C; Dong Z; Kang T; Tang F
    Theranostics; 2018; 8(19):5289-5306. PubMed ID: 30555547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MICAL2 Facilitates Gastric Cancer Cell Migration via MRTF-A-Mediated CDC42 Activation.
    Wang Y; Min P; Qi C; Zhao S; Yu M; Zhang Y; Du J
    Front Mol Biosci; 2021; 8():568868. PubMed ID: 33842533
    [No Abstract]   [Full Text] [Related]  

  • 10. MICAL2 is a novel nucleocytoplasmic shuttling protein promoting cancer invasion and growth of lung adenocarcinoma.
    Zhou W; Liu Y; Gao Y; Cheng Y; Chang R; Li X; Zhou Y; Wang S; Liang L; Duan C; Zhang C
    Cancer Lett; 2020 Jul; 483():75-86. PubMed ID: 32360180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of EGF-induced migration and invasion by sulfated polysaccharide of Sepiella maindroni ink via the suppression of EGFR/Akt/p38 MAPK/MMP-2 signaling pathway in KB cells.
    Jiang W; Tian W; Ijaz M; Wang F
    Biomed Pharmacother; 2017 Nov; 95():95-102. PubMed ID: 28830011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor acts as a negative regulator for bacterium nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via an Src-dependent p38 mitogen-activated protein kinase signaling pathway.
    Mikami F; Gu H; Jono H; Andalibi A; Kai H; Li JD
    J Biol Chem; 2005 Oct; 280(43):36185-94. PubMed ID: 16115866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
    Yang Z; Bagheri-Yarmand R; Wang RA; Adam L; Papadimitrakopoulou VV; Clayman GL; El-Naggar A; Lotan R; Barnes CJ; Hong WK; Kumar R
    Clin Cancer Res; 2004 Jan; 10(2):658-67. PubMed ID: 14760089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).
    Barnes CJ; Bagheri-Yarmand R; Mandal M; Yang Z; Clayman GL; Hong WK; Kumar R
    Mol Cancer Ther; 2003 Apr; 2(4):345-51. PubMed ID: 12700278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.
    Howlin J; Rosenkvist J; Andersson T
    Breast Cancer Res; 2008; 10(2):R36. PubMed ID: 18435854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLC and PI3K pathways are important in the inhibition of EGF-induced cell migration by gefitinib ('Iressa', ZD1839).
    Shien T; Doihara H; Hara H; Takahashi H; Yoshitomi S; Taira N; Ishibe Y; Teramoto J; Aoe M; Shimizu N
    Breast Cancer; 2004; 11(4):367-73. PubMed ID: 15604992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Heregulin impairs EGF induced PLC-γ1 signalling in human breast cancer cells.
    Rommerswinkel N; Keil S; Adawy A; Hengstler JG; Niggemann B; Zänker KS; Dittmar T
    Cell Signal; 2018 Dec; 52():23-34. PubMed ID: 30165102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.
    Sah JF; Eckert RL; Chandraratna RA; Rorke EA
    J Biol Chem; 2002 Mar; 277(12):9728-35. PubMed ID: 11788593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
    Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
    Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition.
    Agelaki S; Spiliotaki M; Markomanolaki H; Kallergi G; Mavroudis D; Georgoulias V; Stournaras C
    Cancer Biol Ther; 2009 Aug; 8(15):1470-7. PubMed ID: 19483462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.